Trial reportNutrition journal2025
Clinical randomized trial of vitamin D and C supplementation in critically ill patients with respiratory failure.
Trial report in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute respiratory failure (ARF) is the most common organ failure, affecting up to 30% of all intensive care unit (ICU) admissions. Since vitamin deficiencies are frequent in critically ill patients, and considering that the two primary mechanisms involved in ARF are inflammation and oxidative stress, this study aims to investigate the effects of co-supplementation of vitamins D and C on inflammatory parameters, oxidative stress, and clinical outcomes in critically ill ARF patients.
methodsIn this double-blind, randomized, placebo-controlled trial, ARF patients admitted to the ICU were randomly assigned to either the intervention group (daily 2000 mg of intravenous vitamin C plus 5000 IU of oral vitamin D) or the control group (placebo). The intervention lasted 10 days, and patients were followed for 90 days, assessing inflammation, oxidative stress parameters, and clinical outcomes.
resultsThirty-four patients in the intervention group and 33 in the control group completed the trial. At the end of the intervention, High-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and malondialdehyde (MDA) were significantly reduced, while total antioxidant capacity (TAC) increased significantly in the intervention group compared to both the baseline and the control group (p < 0.001). Among the clinical outcomes, only the duration of ICU stay was shorter in the intervention group (0.028). However, 90-day survival (HR 0.55; 95% CI 0.21–1.41; P = 0.22) did not show a significant difference between the two groups.
conclusionsOur study concluded that vitamin D and C supplementation may improve inflammation and oxidative status in critically ill ARF patients, reducing ICU stays but not affecting 90-day mortality.
trial registrationThe study has been registered at https://irct.behdasht.gov.ir/ . Number: IRCT20090822002365N29.Registered on 2023-08-05 and it was ethically approved by the Committee of Iran University of Medical Sciences (registration IR.IUMS.REC.1402.210).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.